Literature DB >> 19644040

The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal.

K J Jackson1, J M McIntosh, D H Brunzell, S S Sanjakdar, M I Damaj.   

Abstract

The alpha6 nicotinic acetylcholine receptor (nAChR) subunit is involved in nicotine-stimulated dopamine release in the striatum. It is expressed in brain regions and coexpressed with nAChR subtypes implicated in nicotine dependence behaviors; hence, this subunit may play a role in nicotine dependence. Using the alpha6-selective antagonist alpha-conotoxin H9A;L15A (MII[H9A;L15A]), we determined the role of alpha6* nAChRs in the pharmacological and behavioral effects of nicotine. We measured effects of pretreatment with MII[H9A;L15A] on analgesia, locomotion, and body temperature after a single injection of nicotine. Effects of MII[H9A;L15A] on nicotine reward were measured using the conditioned place preference (CPP) paradigm. We further measured physical (somatic signs and hyperalgesia) and affective [anxiety-related behavior and conditioned place aversion (CPA)] nicotine withdrawal behaviors after extended nicotine exposure. Results showed that MII[H9A;L15A] did not block acute nicotine effects on the behaviors measured. Conversely, MII[H9A:l15A] blocked the expression of nicotine CPP, as well as withdrawal-associated CPA and anxiety-related behavior in the elevated plus maze, but not withdrawal-induced somatic signs or hyperalgesia. These results suggest a role for the alpha6 nAChR subunit in nicotine reward and affective nicotine withdrawal but not acute nicotine-induced or physical withdrawal behaviors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19644040      PMCID: PMC2775251          DOI: 10.1124/jpet.109.155457

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  37 in total

1.  Decrease of ventral tegmental area dopamine neuronal activity in nicotine withdrawal rats.

Authors:  Zhong-Hua Liu; Wen-Qiao Jin
Journal:  Neuroreport       Date:  2004-06-28       Impact factor: 1.837

2.  The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (alpha 5) in the rat central nervous system.

Authors:  E Wada; D McKinnon; S Heinemann; J Patrick; L W Swanson
Journal:  Brain Res       Date:  1990-08-27       Impact factor: 3.252

3.  Adaptations in cholinergic transmission in the ventral tegmental area associated with the affective signs of nicotine withdrawal in rats.

Authors:  Adrie W Bruijnzeel; Athina Markou
Journal:  Neuropharmacology       Date:  2004-09       Impact factor: 5.250

4.  Nicotinic effects on the firing pattern of midbrain dopamine neurons.

Authors:  J Grenhoff; G Aston-Jones; T H Svensson
Journal:  Acta Physiol Scand       Date:  1986-11

5.  Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice.

Authors:  Nicolas Champtiaux; Cecilia Gotti; Matilde Cordero-Erausquin; Denis J David; Cédric Przybylski; Clément Léna; Francesco Clementi; Milena Moretti; Francesco M Rossi; Nicolas Le Novère; J Michael McIntosh; Alain M Gardier; Jean-Pierre Changeux
Journal:  J Neurosci       Date:  2003-08-27       Impact factor: 6.167

6.  Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area.

Authors:  S R Laviolette; D van der Kooy
Journal:  Mol Psychiatry       Date:  2003-01       Impact factor: 15.992

7.  Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

Authors:  Outi Salminen; Karen L Murphy; J Michael McIntosh; John Drago; Michael J Marks; Allan C Collins; Sharon R Grady
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

8.  Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine.

Authors:  Sanna Janhunen; Liisa Ahtee
Journal:  Eur J Pharmacol       Date:  2004-06-28       Impact factor: 4.432

9.  Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.

Authors:  J Michael McIntosh; Layla Azam; Sarah Staheli; Cheryl Dowell; Jon M Lindstrom; Alexander Kuryatov; James E Garrett; Michael J Marks; Paul Whiteaker
Journal:  Mol Pharmacol       Date:  2004-04       Impact factor: 4.436

10.  Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia.

Authors:  Theresa Tritto; Sarah E McCallum; Satori A Waddle; Scott R Hutton; Richard Paylor; Allan C Collins; Michael J Marks
Journal:  Nicotine Tob Res       Date:  2004-02       Impact factor: 4.244

View more
  81 in total

1.  AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.

Authors:  Lawrence Toll; Nurulain T Zaveri; Willma E Polgar; Faming Jiang; Taline V Khroyan; Wei Zhou; Xinmin Simon Xie; Gregory B Stauber; Matthew R Costello; Frances M Leslie
Journal:  Neuropsychopharmacology       Date:  2012-01-25       Impact factor: 7.853

2.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

3.  Expression of functional human α6β2β3* acetylcholine receptors in Xenopus laevis oocytes achieved through subunit chimeras and concatamers.

Authors:  Alexandre Kuryatov; Jon Lindstrom
Journal:  Mol Pharmacol       Date:  2010-10-05       Impact factor: 4.436

Review 4.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

5.  The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice.

Authors:  Monzurul Amin Roni; Shafiqur Rahman
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

6.  Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens.

Authors:  Xiomara A Perez; J Michael McIntosh; Maryka Quik
Journal:  J Neurochem       Date:  2013-10-13       Impact factor: 5.372

7.  The β3 subunit of the nicotinic acetylcholine receptor: Modulation of gene expression and nicotine consumption.

Authors:  Helen M Kamens; Jill Miyamoto; Matthew S Powers; Kasey Ro; Marissa Soto; Ryan Cox; Jerry A Stitzel; Marissa A Ehringer
Journal:  Neuropharmacology       Date:  2015-08-25       Impact factor: 5.250

8.  Effects of nicotine deprivation on current pain intensity among daily cigarette smokers.

Authors:  Lisa R LaRowe; Jesse D Kosiba; Emily L Zale; Joseph W Ditre
Journal:  Exp Clin Psychopharmacol       Date:  2018-07-23       Impact factor: 3.157

Review 9.  Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction.

Authors:  Ruthie E Wittenberg; Shannon L Wolfman; Mariella De Biasi; John A Dani
Journal:  Neuropharmacology       Date:  2020-07-29       Impact factor: 5.250

10.  Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.

Authors:  Andrés P Varani; Ester Aso; Lirane Machado Moutinho; Rafael Maldonado; Graciela N Balerio
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.